Qian Jiang
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Observational Study on Dose Optimization of Olverembatinib in Patients With Chronic Myeloid Leukemia in Chronic or Accelerated Phase (NCT07383298) | Qian Jiang | 2025-12-16 |
Track Qian Jiang automatically
Every clearance here is in the API, with alerts when new ones post.